On May 10, 2017, the USPTO’s Patent Trial and Appeal Board (“Board”) issued a final decision in an inter partes review regarding a petition filed by Smith & Nephew, Inc. and Arthrocare Corp. (“Petitioners”) over the patentability of claims 1, 4, 8, 10-12, 15, 16, 18, 25-28, and 30 recited in U.S. Patent No. 9,179,907 (“the ‘907 Patent”). The ‘907 Patent, which is owned by Arthrex, Inc., is drawn to a knotless suture securing assembly. In the decision, the Board granted the institution of the inter partes review because the Petitioners had established a reasonable likelihood of prevailing with respect to at least 1 of the claims challenged in the petition. The inter partes review remains pending at the Board and is captioned IPR2017-00275.
By: Jacqueline A. DiRamio